Form CORRESP - Correspondence:
SEC Accession No. 0001104659-21-039939
Filing Date
2021-03-22
Accepted
2021-03-22 21:58:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8835
  Complete submission text file 0001104659-21-039939.txt   9790
Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022 212-739-6451
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations